Cargando…

Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma

Background: Malignant mesothelioma (MM) is an aggressive and incurable carcinoma that is primarily caused by asbestos exposure. However, the current diagnostic tool for MM is still under-developed. Therefore, the aim of this study is to explore the diagnostic significance of a strategy that combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Yang, Chenxi, Zhou, Sicheng, Song, Siyu, Jin, Yuyao, Wang, Ding, Liu, Junping, Gao, Yun, Yang, Haining, Mao, Weimin, Chen, Zhongjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304303/
https://www.ncbi.nlm.nih.gov/pubmed/34359365
http://dx.doi.org/10.3390/diagnostics11071281
_version_ 1783727301788172288
author Li, Na
Yang, Chenxi
Zhou, Sicheng
Song, Siyu
Jin, Yuyao
Wang, Ding
Liu, Junping
Gao, Yun
Yang, Haining
Mao, Weimin
Chen, Zhongjian
author_facet Li, Na
Yang, Chenxi
Zhou, Sicheng
Song, Siyu
Jin, Yuyao
Wang, Ding
Liu, Junping
Gao, Yun
Yang, Haining
Mao, Weimin
Chen, Zhongjian
author_sort Li, Na
collection PubMed
description Background: Malignant mesothelioma (MM) is an aggressive and incurable carcinoma that is primarily caused by asbestos exposure. However, the current diagnostic tool for MM is still under-developed. Therefore, the aim of this study is to explore the diagnostic significance of a strategy that combined plasma-based metabolomics with machine learning algorithms for MM. Methods: Plasma samples collected from 25 MM patients and 32 healthy controls (HCs) were randomly divided into train set and test set, after which analyzation was performed by liquid chromatography-mass spectrometry-based metabolomics. Differential metabolites were screened out from the samples of the train set. Subsequently, metabolite-based diagnostic models, including receiver operating characteristic (ROC) curves and Random Forest model (RF), were established, and their prediction accuracies were calculated for the test set samples. Results: Twenty differential plasma metabolites were annotated in the train set; 10 of these metabolites were validated in the test set. The seven metabolites with most significant diagnostic values were taurocholic acid (accuracy = 0.6429), uracil (accuracy = 0.7143), biliverdin (accuracy = 0.7143), tauroursodeoxycholic acid (accuracy = 0.5000), histidine (accuracy = 0.8571), pyrroline hydroxycarboxylic acid (accuracy = 0.8571), and phenylalanine (accuracy = 0.7857). Furthermore, RF based on 20 annotated metabolites showed a prediction accuracy of 0.9286, and its optimized version achieved 1.0000 in the test set. Moreover, the comparison between the samples of peritoneal MM (n = 8) and pleural MM (n = 17) illustrated a significant increase in levels of taurocholic acid and tauroursodeoxycholic acid, as well as an evident decrease in biliverdin. Conclusions: Our results revealed the potential diagnostic value of plasma-based metabolomics combined with machine learning for MM. Further research with large sample size is worthy conducting. Moreover, our data demonstrated dysregulated metabolism pathways in MM, which aids in better understanding of molecular mechanisms related to the initiation and development of MM.
format Online
Article
Text
id pubmed-8304303
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83043032021-07-25 Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma Li, Na Yang, Chenxi Zhou, Sicheng Song, Siyu Jin, Yuyao Wang, Ding Liu, Junping Gao, Yun Yang, Haining Mao, Weimin Chen, Zhongjian Diagnostics (Basel) Article Background: Malignant mesothelioma (MM) is an aggressive and incurable carcinoma that is primarily caused by asbestos exposure. However, the current diagnostic tool for MM is still under-developed. Therefore, the aim of this study is to explore the diagnostic significance of a strategy that combined plasma-based metabolomics with machine learning algorithms for MM. Methods: Plasma samples collected from 25 MM patients and 32 healthy controls (HCs) were randomly divided into train set and test set, after which analyzation was performed by liquid chromatography-mass spectrometry-based metabolomics. Differential metabolites were screened out from the samples of the train set. Subsequently, metabolite-based diagnostic models, including receiver operating characteristic (ROC) curves and Random Forest model (RF), were established, and their prediction accuracies were calculated for the test set samples. Results: Twenty differential plasma metabolites were annotated in the train set; 10 of these metabolites were validated in the test set. The seven metabolites with most significant diagnostic values were taurocholic acid (accuracy = 0.6429), uracil (accuracy = 0.7143), biliverdin (accuracy = 0.7143), tauroursodeoxycholic acid (accuracy = 0.5000), histidine (accuracy = 0.8571), pyrroline hydroxycarboxylic acid (accuracy = 0.8571), and phenylalanine (accuracy = 0.7857). Furthermore, RF based on 20 annotated metabolites showed a prediction accuracy of 0.9286, and its optimized version achieved 1.0000 in the test set. Moreover, the comparison between the samples of peritoneal MM (n = 8) and pleural MM (n = 17) illustrated a significant increase in levels of taurocholic acid and tauroursodeoxycholic acid, as well as an evident decrease in biliverdin. Conclusions: Our results revealed the potential diagnostic value of plasma-based metabolomics combined with machine learning for MM. Further research with large sample size is worthy conducting. Moreover, our data demonstrated dysregulated metabolism pathways in MM, which aids in better understanding of molecular mechanisms related to the initiation and development of MM. MDPI 2021-07-16 /pmc/articles/PMC8304303/ /pubmed/34359365 http://dx.doi.org/10.3390/diagnostics11071281 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Li, Na
Yang, Chenxi
Zhou, Sicheng
Song, Siyu
Jin, Yuyao
Wang, Ding
Liu, Junping
Gao, Yun
Yang, Haining
Mao, Weimin
Chen, Zhongjian
Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma
title Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma
title_full Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma
title_fullStr Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma
title_full_unstemmed Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma
title_short Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma
title_sort combination of plasma-based metabolomics and machine learning algorithm provides a novel diagnostic strategy for malignant mesothelioma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304303/
https://www.ncbi.nlm.nih.gov/pubmed/34359365
http://dx.doi.org/10.3390/diagnostics11071281
work_keys_str_mv AT lina combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma
AT yangchenxi combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma
AT zhousicheng combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma
AT songsiyu combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma
AT jinyuyao combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma
AT wangding combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma
AT liujunping combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma
AT gaoyun combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma
AT yanghaining combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma
AT maoweimin combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma
AT chenzhongjian combinationofplasmabasedmetabolomicsandmachinelearningalgorithmprovidesanoveldiagnosticstrategyformalignantmesothelioma